World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
38652
World Ranking
9202
National Ranking
4745

Frederick F. Lang publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Frederick F. Lang sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 421 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Frederick F. Lang D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Frederick F. Lang sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2017 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Frederick F. Lang is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the intersection of medicine, biochemistry, genetics, and molecular biology, with a particular emphasis on genetics, molecular biology, oncology, immunology, and pulmonary and respiratory medicine.

The research topics covered by Frederick F. Lang include:

  • Glioma Diagnosis and Treatment
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Brain Metastases and Treatment
  • Immune cells in cancer
  • Neuroinflammation and Neurodegeneration Mechanisms

Several frequent coauthors have collaborated extensively with Frederick F. Lang, including Joy Gumin, Juàn Fueyo, Candelaria Gomez-Manzano, Brittany C. Parker Kerrigan, and Sanjay K. Singh.

The scientist has published research in numerous venues, with the most notable publication outlets being:

  • Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Neuro-Oncology Advances
  • Nature Communications

Examples of recent papers authored or coauthored by Frederick F. Lang include:

  • Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target (2022, Nature Communications)
  • Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma (2022, New England Journal of Medicine)
  • Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells (2021, Journal of Clinical Investigation)
  • Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial (2023, Nature Medicine)
  • Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment (2020, Cancer Discovery)

Frederick F. Lang was awarded the Fellow of the American Association for the Advancement of Science (AAAS) in 2017.

Best Publications

  • A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

    Michel Lacroix;Dima Abi-Said;Daryl R. Fourney;Ziya L. Gokaslan

  • Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

    Eric L Chang;Jeffrey S Wefel;Kenneth R Hess;Pamela K Allen

  • Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

    Adrian Ally;Miruna Balasundaram;Rebecca Carlsen;Eric Chuah

  • Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas

    Akira Nakamizo;Frank Marini;Toshiyuki Amano;Asadullah Khan

  • Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

    Krishna P.L. Bhat;Veerakumar Balasubramaniyan;Brian Vaillant;Ravesanker Ezhilarasan

  • Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

    Anita Mahajan;Salmaan Ahmed;Mary Frances McAleer;Jeffrey S Weinberg

  • Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

    Frederick F Lang;Charles Conrad;Candelaria Gomez-Manzano;W K Alfred Yung

  • Limitations of stereotactic biopsy in the initial management of gliomas

    Robert J. Jackson;Gregory N. Fuller;Dima Abi-Said;Frederick F. Lang

  • Transthoracic vertebrectomy for metastatic spinal tumors

    Ziya L. Gokaslan;Julie E. York;Garrett L. Walsh;Ian E. McCutcheon

  • Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results

    Frederick F. Lang;Janet M. Bruner;Gregory N. Fuller;Kenneth Aldape

  • IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection

    Jason Beiko;Dima Suki;Kenneth R Hess;Benjamin D. Fox;Benjamin D. Fox

  • FoxM1B Is Overexpressed in Human Glioblastomas and Critically Regulates the Tumorigenicity of Glioma Cells

    Mingguang Liu;Bingbing Dai;Shin Hyuk Kang;Kechen Ban

  • Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.

    Tadahisa Shono;Philip J. Tofilon;Janet M. Bruner;Olubunmi Owolabi

  • Pathways leading to glioblastoma multiforme : a molecular analysis of genetic alterations in 65 astrocytic tumors

    Frederick F. Lang;Douglas C. Miller;Maxim Koslow;Elizabeth W. Newcomb

  • The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

    Krishna P.L. Bhat;Krishna P.L. Bhat;Katrina L. Salazar;Katrina L. Salazar;Veerakumar Balasubramaniyan;Veerakumar Balasubramaniyan;Veerakumar Balasubramaniyan;Khalida Wani

  • Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

    Juan Fueyo;Ramon Alemany;Candelaria Gomez-Manzano;Gregory N. Fuller

  • Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery

    Nicholas F. Marko;Robert J. Weil;Jason L. Schroeder;Frederick F. Lang

  • Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

    Sandeep Kunwar;Michael D. Prados;Susan M. Chang;Mitchel S. Berger

  • An implantable guide-screw system for brain tumor studies in small animals.

    Sumeer Lal;Michel Lacroix;Philip Tofilon;Gregory N Fuller

  • Examination of the Therapeutic Potential of Delta-24-RGD in Brain Tumor Stem Cells: Role of Autophagic Cell Death

    Hong Jiang;Candelaria Gomez-Manzano;Hiroshi Aoki;Hiroshi Aoki;Marta M. Alonso

Frequent Co-Authors

Raymond Sawaya
Raymond Sawaya The University of Texas MD Anderson Cancer Center
Gregory N. Fuller
Gregory N. Fuller The University of Texas MD Anderson Cancer Center
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center
Hong Jiang
Hong Jiang Central South University
Waldemar Priebe
Waldemar Priebe The University of Texas MD Anderson Cancer Center
Kenneth R. Hess
Kenneth R. Hess The University of Texas MD Anderson Cancer Center
Roel G.W. Verhaak
Roel G.W. Verhaak The Jackson Laboratory
Michael Andreeff
Michael Andreeff The University of Texas MD Anderson Cancer Center
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
wei zhang
wei zhang Wake Forest University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of flexible online degree options and career pathways. For registered nurses seeking advancement, rn to bsn online programs are popular. These programs build on existing nursing skills, offering an affordable and convenient route to higher qualifications without disrupting your career.

If you’re changing careers or hold a non-nursing bachelor’s degree, direct msn programs online provide a fast track to advanced nursing roles, even for those new to the field.

For applicants concerned about competitive admissions, there are easiest nursing schools to get into that lower barriers without compromising credibility, making the transition into the medical field more achievable.

Finally, those interested in healthcare administration or supporting roles might consider online medical coding classes with financial aid, which offer training for in-demand medical office positions.

These varied online pathways enable students from different backgrounds to enter medicine or related health professions, suiting a wide range of educational needs and career goals.

Best Scientists Citing Frederick F. Lang

Trending Scientists

Recently Published Articles